Patent: 10,562,974
✉ Email this page to a colleague
Summary for Patent: 10,562,974
Title: | Methods of administering IgG1 antibodies and methods of suppressing angiogenesis |
Abstract: | A method of suppressing angiogenesis involves administering to a subject an isolated Fc fragment of an IgG1 antibody, or an IgG1 antibody. |
Inventor(s): | Ambati; Jayakrishna (Lexington, KY), De Falco; Sandro (Naples, IT) |
Assignee: | University of Kentucky Research Foundation (Lexington, KY) |
Application Number: | 14/772,243 |
Patent Claims: | see list of patent claims |
Details for Patent 10,562,974
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Hoffmann-la Roche Inc. | ZENAPAX | daclizumab | Injection | 103749 | 12/10/1997 | ⤷ Try a Trial | 2033-03-13 |
Swedish Orphan Biovitrum Ab (publ) | SYNAGIS | palivizumab | For Injection | 103770 | 06/19/1998 | ⤷ Try a Trial | 2033-03-13 |
Swedish Orphan Biovitrum Ab (publ) | SYNAGIS | palivizumab | Injection | 103770 | 07/23/2004 | ⤷ Try a Trial | 2033-03-13 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2033-03-13 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |